In line with the trend to reduced fibrosis, expression of Col1a1 and Col4a1 was reduced upon Mastiha intake, but the difference to NASH control mice was not statistically significant. The gene discussed is COL4A1; the disease is metabolic dysfunction-associated steatohepatitis.